Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-04, Stock:NVS, The news for the past five days is as follows:
2019-09-27: NEWS1: AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug.NEWS2: Incyte (INCY) Stock Up 16% YTD on Strong Jakafi Performance.
2019-09-30: NEWS1: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Novartis AG Investors of Important Deadline in Securities Class Action First Filed by the Firm – NVS.NEWS2: CVS pulls Zantac and its generic brand over possible cancer link.NEWS3: Roche's (RHHBY) Rituxan Receives FDA Nod for Label Expansion.NEWS4: CBMG: Initiating Coverage of Cellular Biomedicine Group; Multiple Cell-Based Therapies to Treat Cancer and Degenerative Diseases….
2019-10-01: NEWS1: Biogen Stock Flailed On Alzheimer's Flop — Is This Biotech Stock A Buy Now?.NEWS2: Bausch shares slide after it sues Novartis’ unit Sandoz over blockbuster drug patents.NEWS3: Bausch files suit against Novartis unit Sandoz for infringing patents on Xifaxan 550 mg tablets.NEWS4: Novartis and Microsoft join forces to develop drugs using AI.
2019-10-02: NEWS1: Novartis (NVS) Announces Data on Asthma Drugs & Kisqali.NEWS2: The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data.NEWS3: Bausch shares slide on suit against Novartis unit Sandoz over blockbuster drug patents.
2019-10-03: NEWS1: Bausch Files Lawsuit Against Novartis' Sandoz, Shares Down.NEWS2: Novartis Reports Additional Data on Spondylitis Drug Cosentyx.

Answer: Rise